TY - JOUR
T1 - Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration
T2 - Relation to hepatic vein pressure gradient
AU - Uehara, Hideo
AU - Akahoshi, Tomohiko
AU - Tomikawa, Morimasa
AU - Kinjo, Nao
AU - Hashimoto, Naotaka
AU - Nagao, Yoshihiro
AU - Kamori, Masahiro
AU - Maehara, Yoshihiko
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2012/1
Y1 - 2012/1
N2 - Background and Aims: Balloon-occluded retrograde transvenous obliteration (B-RTO) is an effective treatment for gastric varices (GVx), as well as hepatic encephalopathy. The aim of this study was to examine the changes of the hepatic vein pressure gradient (HVPG) after B-RTO and determine the relation between the changes of HVPG and liver function. Patients and Methods: B-RTO was performed in 30 patients with GVx and hepatic encephalopathy. HVPG was measured in 19 of 30 patients both before and after B-RTO. Results: The B-RTO was successful in all patients. The GVx and hepatic encephalopathy were improved, and no recurrence or bleeding was observed within the follow- up period. The serum albumin and prothrombin activity were significantly improved 6months after B-RTO in all patients. HVPG was elevated 44% above the baseline after B-RTO. Liver function significantly improved 6months after B-RTO in patients whose HVPG increased≥20% from baseline. Conclusion: An elevated HVPG after B-RTO is one aspect of the effect of liver function, and an HVPG increase of≥20% from baseline is a predictive factor for obtaining an improvement of liver function.
AB - Background and Aims: Balloon-occluded retrograde transvenous obliteration (B-RTO) is an effective treatment for gastric varices (GVx), as well as hepatic encephalopathy. The aim of this study was to examine the changes of the hepatic vein pressure gradient (HVPG) after B-RTO and determine the relation between the changes of HVPG and liver function. Patients and Methods: B-RTO was performed in 30 patients with GVx and hepatic encephalopathy. HVPG was measured in 19 of 30 patients both before and after B-RTO. Results: The B-RTO was successful in all patients. The GVx and hepatic encephalopathy were improved, and no recurrence or bleeding was observed within the follow- up period. The serum albumin and prothrombin activity were significantly improved 6months after B-RTO in all patients. HVPG was elevated 44% above the baseline after B-RTO. Liver function significantly improved 6months after B-RTO in patients whose HVPG increased≥20% from baseline. Conclusion: An elevated HVPG after B-RTO is one aspect of the effect of liver function, and an HVPG increase of≥20% from baseline is a predictive factor for obtaining an improvement of liver function.
UR - http://www.scopus.com/inward/record.url?scp=84155174943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84155174943&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1746.2011.06835.x
DO - 10.1111/j.1440-1746.2011.06835.x
M3 - Article
C2 - 21722180
AN - SCOPUS:84155174943
SN - 0815-9319
VL - 27
SP - 137
EP - 141
JO - Journal of Gastroenterology and Hepatology (Australia)
JF - Journal of Gastroenterology and Hepatology (Australia)
IS - 1
ER -